找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Cardiorenal Syndrome; Mechanisms, Risk and Adel E. Berbari,Giuseppe Mancia Book 2010 Springer-Verlag Milan 2010 Chronic kidney disease.card

[復(fù)制鏈接]
樓主: T-cell
21#
發(fā)表于 2025-3-25 04:47:27 | 只看該作者
Discussion And Conclusion Of The Study,iorenal association and to pinpoint features that are specific to each clinical entity, whether the initial insult is renal or cardiac. A detailed discussion of the various aspects of cardiorenal association are well covered in the following chapters.
22#
發(fā)表于 2025-3-25 10:59:49 | 只看該作者
Novice Writers and Scholarly Publication 88% of patients with chronic kidney disease never reach end-stage renal disease, as the majority of them die due to cardiovascular disease. Thus, understanding the role of renal parenchymal disease as an independent cardiovascular risk state — i.e., renocardiac syndrome — is very important. In this
23#
發(fā)表于 2025-3-25 12:35:01 | 只看該作者
24#
發(fā)表于 2025-3-25 17:50:13 | 只看該作者
Novice Writers and Scholarly Publicationardiovascular events can be prevented. As the cardiorenal process advances, atherosclerotic vascular damage progresses, and subclinical organ damage can be detected. Chronic kidney disease is included at this stage, and a number of conditions associated with renal dysfunction become novel risk facto
25#
發(fā)表于 2025-3-25 22:43:58 | 只看該作者
https://doi.org/10.1007/978-3-662-28359-2lanation as to why increased albuminuria not only predicts renal disease risk but also CVD risk. Treatments that lower albuminuria are associated with cardiovascular protection, as demonstrated in randomized controlled trials of diabetic as well as hypertensive patients. There is preliminary evidenc
26#
發(fā)表于 2025-3-26 03:59:42 | 只看該作者
https://doi.org/10.1007/978-3-030-89877-9and vascular damage. In addition, the chapter reviews trial data that evaluated microalbuminuria for its prognostic significance on cardiovascular outcomes, as well as existing therapeutic interventions for reducing urinary albumin excretion in patients with high cardiovascular risk.
27#
發(fā)表于 2025-3-26 08:20:06 | 只看該作者
28#
發(fā)表于 2025-3-26 09:07:45 | 只看該作者
Progress in Inflammation Research lipid abnormalities. Beta blockers, aspirin and angiotensinconverting (ACE) inhibitors are likely effective therapies for treating coronary artery disease (CAD), but these remain very much underutilized. Similarly, despite evidence that coronary revascularization is useful in CKD and dialysis patie
29#
發(fā)表于 2025-3-26 14:21:19 | 只看該作者
Strategies for Deep Customer Engagement, condition of this deadly syndrome, sometimes also called cardiorenal-anemia syndrome. In patients with heart failure, renal function has a powerful prognostic significance. This is true both in chronic heart failure over a long follow-up and in acutely decompensated heart failure for in-hospital mo
30#
發(fā)表于 2025-3-26 20:52:25 | 只看該作者
everal uremia related factors such as uncontrolled hypertension, disturbed glucose insulin metabolism, microalbuminuria, phosphate retention, secondary hyperparathyroidism, myocardial and vascular calcification978-88-470-5609-1978-88-470-1463-3
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-23 01:05
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
长白| 江西省| 阿尔山市| 通辽市| 天长市| 洞口县| 淮北市| 高要市| 探索| 呼伦贝尔市| 邵武市| 盘锦市| 万州区| 漠河县| 新邵县| 潞西市| 孙吴县| 班戈县| 武乡县| 绵阳市| 壶关县| 京山县| 永济市| 南乐县| 金沙县| 张家口市| 松桃| 安新县| 马山县| 旬阳县| 甘肃省| 高青县| 永城市| 全椒县| 朝阳区| 江陵县| 南和县| 论坛| 林口县| 衡阳县| 永丰县|